MTOR and adrenal cortex carcinoma: Indeed, recurrent mutations resulting in activation of the PI3K‐AKT‐mTOR pathway were found in 30% of ACC21, and activated (phosphorylated) AKT isoforms and downstream mTOR is enhanced in ACC as compared to healthy adjacent tissue 22, 23.